US Patent Issued to Sepsia Therapeutics on Oct. 27 for "Bacterial-binding peptides for treatment of infectious diseases and related inflammatory processes" (Spanish Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,441, issued on Oct. 27, was assigned to Sepsia Therapeutics S.L. (L'hospitalet de Llobergat, Spain).

"Bacterial-binding peptides for treatment of infectious diseases and related inflammatory processes" was invented by Francisco Lozano Soto (Barcelona, Spain) and Mario Martinez Florensa (Barcelona, Spain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the field of medicine and provides pharmaceutical compositions comprising one or more of the following isolated amino acid sequences comprising or, alternatively, consisting of, SEQ ID No.: 3, and/or SEQ ID No.: 1, and/or SEQ ID No.: 2, kits and conjugates comprising one ...